
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 14, 2025, titled "Closure of USFDA inspection at Zydus API manufacturing plant at Ambernath, Maharashtra".
Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 14, 2025, titled "Closure of USFDA inspection at Zydus API manufacturing plant at Ambernath, Maharashtra".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences